1-[1-(1,2-dihydroacenaphthylen-1-yl)piperidin-4-yl]-3-(2-morpholin-4-yl-2-oxoethyl)benzimidazol-2-one;hydrochloride

C30H33ClN4O3 — CID 23063005

IUPAC1-[1-(1,2-dihydroacenaphthylen-1-yl)piperidin-4-yl]-3-(2-morpholin-4-yl-2-oxoethyl)benzimidazol-2-one;hydrochloride
SMILESCl.O=C(Cn1c(=O)n(C2CCN(C3Cc4cccc5cccc3c45)CC2)c2ccccc21)N1CCOCC1
InChIInChI=1S/C30H32N4O3.ClH/c35-28(32-15-17-37-18-16-32)20-33-25-9-1-2-10-26(25)34(30(33)36)23-11-13-31(14-12-23)27-19-22-7-3-5-21-6-4-8-24(27)29(21)22;/h1-10,23,27H,11-20H2;1H
InChIKeyYOKHRKNKLYVHHH-UHFFFAOYSA-N
MW533.07 g/mol
LogP4.17
Rot. Bonds4

About 1-[1-(1,2-dihydroacenaphthylen-1-yl)piperidin-4-yl]-3-(2-morpholin-4-yl-2-oxoethyl)benzimidazol-2-one;hydrochloride

1-[1-(1,2-dihydroacenaphthylen-1-yl)piperidin-4-yl]-3-(2-morpholin-4-yl-2-oxoethyl)benzimidazol-2-one;hydrochloride (PubChem CID 23063005) has the molecular formula C30H33ClN4O3 and a molecular weight of 533.07 g/mol. Its IUPAC name is 1-[1-(1,2-dihydroacenaphthylen-1-yl)piperidin-4-yl]-3-(2-morpholin-4-yl-2-oxoethyl)benzimidazol-2-one;hydrochloride.

Molecular Properties

Compound Name1-[1-(1,2-dihydroacenaphthylen-1-yl)piperidin-4-yl]-3-(2-morpholin-4-yl-2-oxoethyl)benzimidazol-2-one;hydrochloride
PubChem CID23063005
Molecular FormulaC30H33ClN4O3
Molecular Weight533.07 g/mol
Exact Mass532.22
IUPAC Name1-[1-(1,2-dihydroacenaphthylen-1-yl)piperidin-4-yl]-3-(2-morpholin-4-yl-2-oxoethyl)benzimidazol-2-one;hydrochloride
SMILESCl.O=C(Cn1c(=O)n(C2CCN(C3Cc4cccc5cccc3c45)CC2)c2ccccc21)N1CCOCC1
InChIInChI=1S/C30H32N4O3.ClH/c35-28(32-15-17-37-18-16-32)20-33-25-9-1-2-10-26(25)34(30(33)36)23-11-13-31(14-12-23)27-19-22-7-3-5-21-6-4-8-24(27)29(21)22;/h1-10,23,27H,11-20H2;1H
InChIKeyYOKHRKNKLYVHHH-UHFFFAOYSA-N
XLogP4.17
TPSA59.71 Ų
H-Bond Donors
H-Bond Acceptors6
Rotatable Bonds4
Heavy Atoms38
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500533.07
LogP ≤ 54.17
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 106

Analyze 1-[1-(1,2-dihydroacenaphthylen-1-yl)piperidin-4-yl]-3-(2-morpholin-4-yl-2-oxoethyl)benzimidazol-2-one;hydrochloride with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 1-[1-(1,2-dihydroacenaphthylen-1-yl)piperidin-4-yl]-3-(2-morpholin-4-yl-2-oxoethyl)benzimidazol-2-one;hydrochloride?
The IUPAC name of 1-[1-(1,2-dihydroacenaphthylen-1-yl)piperidin-4-yl]-3-(2-morpholin-4-yl-2-oxoethyl)benzimidazol-2-one;hydrochloride (CID 23063005) is 1-[1-(1,2-dihydroacenaphthylen-1-yl)piperidin-4-yl]-3-(2-morpholin-4-yl-2-oxoethyl)benzimidazol-2-one;hydrochloride.
What is the SMILES notation for 1-[1-(1,2-dihydroacenaphthylen-1-yl)piperidin-4-yl]-3-(2-morpholin-4-yl-2-oxoethyl)benzimidazol-2-one;hydrochloride?
The canonical SMILES for 1-[1-(1,2-dihydroacenaphthylen-1-yl)piperidin-4-yl]-3-(2-morpholin-4-yl-2-oxoethyl)benzimidazol-2-one;hydrochloride is Cl.O=C(Cn1c(=O)n(C2CCN(C3Cc4cccc5cccc3c45)CC2)c2ccccc21)N1CCOCC1.
What is the InChIKey of 1-[1-(1,2-dihydroacenaphthylen-1-yl)piperidin-4-yl]-3-(2-morpholin-4-yl-2-oxoethyl)benzimidazol-2-one;hydrochloride?
The InChIKey is YOKHRKNKLYVHHH-UHFFFAOYSA-N. The full InChI is InChI=1S/C30H32N4O3.ClH/c35-28(32-15-17-37-18-16-32)20-33-25-9-1-2-10-26(25)34(30(33)36)23-11-13-31(14-12-23)27-19-22-7-3-5-21-6-4-8-24(27)29(21)22;/h1-10,23,27H,11-20H2;1H.
What are the key properties of 1-[1-(1,2-dihydroacenaphthylen-1-yl)piperidin-4-yl]-3-(2-morpholin-4-yl-2-oxoethyl)benzimidazol-2-one;hydrochloride?
1-[1-(1,2-dihydroacenaphthylen-1-yl)piperidin-4-yl]-3-(2-morpholin-4-yl-2-oxoethyl)benzimidazol-2-one;hydrochloride has a molecular weight of 533.07 g/mol, XLogP of 4.17, 4 rotatable bonds, 0 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for 1-[1-(1,2-dihydroacenaphthylen-1-yl)piperidin-4-yl]-3-(2-morpholin-4-yl-2-oxoethyl)benzimidazol-2-one;hydrochloride is sourced from PubChem (CID 23063005), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).